HOW THE DEA’s 94% FALSE POSITIVE PROSECUTION ENGINES INCARCERATE THOUSANDS OF U.S. PHYSICIANS, DENTISTS, PHARMACISTS, AND NURSE PRACTITIONERS

republished from doctors of courage in youarewithinthenorms.com

NORMAN J CLEMENT RPH., DDS, NORMAN L. CLEMENT PHARM-TECH, MALACHI F. MACKANDAL PHARMD, BELINDA BROWN-PARKER, IN THE SPIRIT OF JOSEPH SOLVO ESQ., INC., SPIRIT OF REV. IN THE SPIRIT OF WALTER R. CLEMENT BS., MS, MBA. HARVEY JENKINS, MD, PH.D., IN THE SPIRIT OF C.T. VIVIAN, JELANI ZIMBABWE CLEMENT, BS., M.B.A., IN THE SPIRIT OF THE HON. PATRICE LUMUMBA, IN THE SPIRIT OF ERLIN CLEMENT SR., EVELYN J. CLEMENT, WALTER F. WRENN III., MD., JULIE KILLINGSWORTH, RENEE BLARE, RPH, DR. TERENCE SASAKI, MD LESLY POMPY MD., CHRISTOPHER RUSSO, MD., NANCY SEEFELDT, WILLIE GUINYARD BS., JOSEPH WEBSTER MD., MBA, BEVERLY C. PRINCE MD., FACS., NEIL ARNAND, MD., RICHARD KAUL, MD., IN THE SPIRIT OF LEROY BAYLOR, JAY K. JOSHI MD., MBA, AISHA GARDNER, ADRIENNE EDMUNDSON, ESTER HYATT PH.D., WALTER L. SMITH BS., IN THE SPIRIT OF BRAHM FISHER ESQ., MICHELE ALEXANDER MD., CUDJOE WILDING BS, MARTIN NJOKU, BS., RPH., IN THE SPIRIT OF DEBRA LYNN SHEPHERD, BERES E. MUSCHETT, STRATEGIC ADVISORS

documented 94% false positive rate is producing a 99% conviction

THE DEA ALGORITHMIC GUILLOTINE

In the quiet corridors of federal courtrooms, a statistical paradox masquerades as justice: a U.S. Government forensic tool with a documented 94% false positive rate is producing a 99% conviction rate. This is not an accident of data; it is the engineered outcome of a system built not on medical evidence but on corporate espionage repurposed as state power.

At the heart of this machinery stands Deloitte, the global consulting giant that, in 2007, deployed former CIA officers, including John Kiriakou, the operative who helped capture Abu Zubaydah, to eavesdrop in Orlando convention center bathrooms and steal “abandoned” financial documents from a rival firm, BearingPoint. That operation, though never deemed illegal, was a masterclass in human-led corporate espionage, yielding the “holy grail” of competitor intelligence: revenue projections, client lists, and strategic vulnerabilities.

The 94% False Positive Engine Meets the 99% Conviction Machine

By 2009, Deloitte used that intelligence to acquire BearingPoint’s North American public services unit for $350 million, instantly doubling its federal footprint. Today, Deloitte commands $3.7 billion in federal contracts and ranks #25 among all U.S. government contractors—a transformation fueled not by organic growth, but by strategic intelligence gathering bordering on the clandestine.

From Bathroom Eavesdropping to Black-Box Algorithms

But Deloitte did not stop at human spies. It digitized them.  The same competitive intelligence unit that once hid in restrooms to overhear panicked consultants now builds AI-driven surveillance platforms for the U.S. government, including the DEA’s Nemesis system, powered by the Isolation Forest algorithm.  This is not a metaphorical evolution; it is a direct lineage. Deloitte’s 2007 playbook collects non-public data, exploits asymmetry, manufactures advantage, and has been automated, scaled, and weaponized against physicians.  Where Kiriakou once scribbled notes in a bathroom stall, Isolation Forest now auto-generates “Anomaly Risk Scores” based on 69+ non-clinical factors:

–“Private pay” prescriptions (a proxy for poverty)

– “Distance to pharmacy” (a proxy for rural Black communities)

– “Criminal record” and “drug charge” history (a proxy for race)

– “Trinity” drug combinations (a proxy for complex pain)

None of these factors assesses medical necessity. All of them encode socioeconomic and racial bias under the guise of actuarial neutrality. And just as Deloitte’s spies in Orlando cherry-picked BearingPoint’s most vulnerable moments, the Nemesis system cherry-picks the top 2% of statistical outliers from a physician’s practice—patients who, by definition, require atypical care.

In United States v. Anand, this yielded a sample so skewed that defense expert Ryan Vaughn calculated its random occurrence probability at less than 1 in 2 million. Five of the 14 government-selected patients were among Dr. Anand’s top 10 highest-dose cases—a selection so extreme it defies statistical legitimacy.

FROM DOCTOR PATIENT FORUM THE TRUTH IS OUT

As Debra Houry steps down from the CDC amid discussions of conflicts of interest and committee-stacking in vaccine guideline processes, it’s an opportune time to look back at past instances where similar concerns were raised, such as the creation, implementation, and impact of the 2016 CDC Opioid Prescribing Guideline.

The hypocrisy here is striking: Houry was at CDC overseeing the 2016 opioid guideline, one of the most conflict-ridden, committee-stacked processes in recent memory, yet now she’s sounding alarms about conflicts in vaccine guidance.

In 2022 we co-authored a piece on Pallimed, “Undisclosed Conflicts of Interest by Physicians Creating the CDC Opioid Prescribing Guidelines: Bad Faith or Incompetence?” (read here). It documented how many of the physicians who shaped that guideline failed to disclose conflicts of interest, both financial and intellectual, at the very moment transparency was most needed.

Key points from our analysis:

• Roughly 72% of “qualifying policy articles” by these doctors failed to disclose conflicts as defined by the CDC itself.
• Authors came into the process with pre-existing advocacy positions and even financial conflicts tied to systematic reviews or expert witness work.
• The panel was stacked with voices already committed to restrictive policy, while the patients most harmed by it were excluded.
• Hard dosing thresholds, supposedly for clarity, were over-applied and weaponized — leading to widespread patient abandonment.
• Meanwhile, the narrative that “doctor prescribing caused the overdose crisis” was pushed despite fentanyl already being the primary driver.

Why it matters today:
When Houry now raises concerns about stacked committees and expert witness bias in vaccine guidelines, it underscores a pattern. Public health guidelines are only as trustworthy as the independence, transparency, and diversity of the committees that create them. The opioid guideline shows what happens when those principles are ignored: policies that harm patients while failing to achieve their stated goals.

Moving forward, we need:

1. Full disclosure of financial and intellectual conflicts from all guideline authors.
2. Balanced committees that include a diversity of perspectives, especially affected patients.
3. Transparent COI management, with recusal where appropriate.
4. Post-implementation monitoring of harms and unintended consequences.
5. Oversight of guideline development when public health stakes are high.

DONATE LEGAL DEFENSE

OR SEND

TO CASH APP:$docnorm

ZELLE 3135103378

ALL WATCHED OVER BY MACHINES OF LOVING GRACE

BE SURE TO DONATE TO THE MARK IBSEN GOFUNDME DEFENSE FUND, WHERE THE SON ALWAYS RISES!!!

FOR NOW, YOU ARE

WITHIN

THE NORMS